Table of Contents
Understanding the distinction between brand and generic medication names is crucial for pharmtechs. Empagliflozin serves as a prime example of this dynamic, with its brand name being Jardiance and its generic name being empagliflozin.
What is Empagliflozin?
Empagliflozin is a medication used primarily to manage type 2 diabetes. It belongs to the class of drugs known as SGLT2 inhibitors, which work by preventing the kidneys from reabsorbing glucose, thereby lowering blood sugar levels.
Brand Name: Jardiance
Jardiance is the proprietary brand name under which empagliflozin is marketed. It is manufactured by Boehringer Ingelheim and is available by prescription. The brand name often signifies specific formulations, packaging, and marketing strategies.
Generic Name: Empagliflozin
The generic name, empagliflozin, refers to the active pharmaceutical ingredient (API). Generic versions are usually less expensive and are bioequivalent to the brand-name drug, offering the same therapeutic benefits.
Differences Between Brand and Generic Empagliflozin
- Cost: Generic empagliflozin is typically more affordable.
- Appearance: Packaging and pill color may differ.
- Manufacturers: Multiple companies may produce generics, whereas the brand is produced by a single manufacturer.
- Regulation: Both must meet strict FDA standards for safety, efficacy, and quality.
Implications for Pharmtechs
Pharmtechs should be familiar with both names to ensure accurate dispensing, patient counseling, and inventory management. Recognizing that generic empagliflozin is equivalent to Jardiance helps in providing cost-effective options to patients without compromising quality.
Key Takeaways
- Empagliflozin is the active ingredient in Jardiance and generic formulations.
- Both are therapeutically equivalent and regulated for safety and efficacy.
- Understanding brand vs. generic names aids in patient education and medication adherence.
Staying informed about medication nomenclature enhances the role of pharmtechs in healthcare delivery, ensuring patients receive the appropriate medication at the right cost.